Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2593-2597

  Cajot, Jean François ^a   Sordat, Isabelle ^a   Silvestre, Timothée ^a   Sordat, Bernard ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER LOCALIZATION; CELL ADHESION; CELL MIGRATION; COLON CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANTIGENS, CD; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; COLONIC NEOPLASMS; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; PERITONEAL NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030834148     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Marshall, J. F., and Hart, I. R. The role of α v-inlegrins in tumour progression and metastasis. Semin. Cancer Biol., 7: 129-138, 1996.
2. Ikeyama, S., Koyama, M., Yamaoko, M., Sasada, R., and Miyuke, M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. Exp. Med., 177: 1231-1237, 1993.
3. Boucheix, C., Nguyen-van-Cong, Perrot, J. Y., Foubert, C., Gross, M. S., Weil, D., Laisney, V., Rosenfeld, C., and Frezal, J. Assignment to chromosome 12 of the gene coding for the human cell surface antigen CD9(p24) using the monoclonal antibody ALB6. Ann. Genet., 28: 19-24. 1985.
4. Wright, M. D., and Tomlinson, M. G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today, 15: 588-594, 1994.
5. Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C., Billard, M., Conjcaud, H., and Boucheix C. CD9, CD63, CD81, and CD82 are components of a tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol., 26: 2657-2665, 1996.
6. Horejsi, V., and Vlcek, C. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53, and CD63. FFBS Lett., 288: 1-4, 1991.
7. Masellis-Smilh, A., and Shaw, A. R. CD9-regulaled adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibrohlasts through de novo recognition of fibronectin. J. Immunol., 152: 2768-2777, 1994.
8. Miyuke, M., Koyama M., Seno, M., and Ikeyama, S. Identification of the motilityrelated protein (MRP-1), recognised by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med., 174: 1347-1354, 1991.
9. Shaw, A. R., Domanska, A., Muk, A., Gilchrisi, A., Dobler, K., Visser, L., Poppema, S., Fliegel, L., Letarte, M., and Willett, B. J. Ectopic expression of human and feline CD9 in a human B cell line confers β1 integrin-dependent motilily on fihronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem., 270: 24092-24099, 1995.
10. Schlaeppi, M., Ruegg, C., Tran-Thang, C., Chapuis, G., Tevaerai, H., Lahm, H., and Sordat, B. Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix. Cell Adhes. Commun., 4: 439-455, 1997.
11. Liang, P., and Pardee, A. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
12. Gough, N. M. Rapid and quantitative preparation of eytoplasmic RNA from small numbers of cells. Anul. Biochem., 173: 93-95, 1988.
13. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds.). Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
14. Bao, L., Loda, M., Janmey, P. A., Stewart, R., Anand-Apte, B., and Zetter, B. R. Thymosin b15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat. Med., 2: 1322-1328, 1996.
15. Francia, G., Mitchell, S.D., Moss, S. E., Hanby, A. M., Marshall, J. F., and Hart, I. R. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res., 56: 3855-3858, 1996.
16. Miyake, M., Nakano, K., Ieki, Y., Adachi, M., Huang, C. L., Itoi, S., Koh, T., and Taki, T. Motility-related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res., 55: 4127-4131, 1995.
17. Higashiyama, M., Taki, T., Ieki, Y., Adachi, M., Huang, C. L., Koh, T., Kodama, K., Doi, O., and Miyake, M. Reduced motility-related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res., 55: 6040-6044, 1995.
18. Lafrenie, R. M., and Yamada, K. M. Integrin-dependent signal transduclion. J. Cell. Biochem., 61: 543-553, 1996.
19. Miyake, M., Nakano, K., Itoi, S. I., Koh, T., and Taki, T. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res., 56: 1244-1249, 1996.
20. Si, Z., and Hersey, P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int. J. Cancer, 54: 37-43, 1993.
21. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAll, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
22. Radford, K. J., and Mallesch, J. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int. J. Cancer. 62: 631-635, 1995.